Laboratory Core B's primary aim is to provide accurate, timely, centralized diagnostic test services to the projects and to Clinical Core A using the facilities of the Virology Division at University of Washington's (""""""""UW"""""""") Department of Laboratory Medicine. The UW Virology Lab at Seattle Children's'Hospital (UW-SCH) will provide HSV serology, HSV culture, arid banking of sera and viral isolates. UW-SCH will also direct the serology testing for other viral pathogens that is required by Projects 1, 2, and 4. Dr. Rhoda Ashley Morrow, Core B Leader, directed the UW-SCH lab from 1983-2010 and continues to direct its Serology Section. The second Core B lab, """"""""UW-PCR"""""""" is located within the UW Virology Division's Molecular Diagnostic Laboratory. This lab detects viral pathogens by amplifying their genetic material by polymerase chain reaction (PCR) methods. Dr. MeeiLi Huang has developed several generations of HSV PCR tests since the mid-1990s and will continue to provide the leadership for this testing. UW-PCR staff will coordinate the sample preparation for HLA markers (Projects 2, 3 and 4) and will manage specimen repositories of HSV DNA and human DNA in support of the proposed projects.
The second aim of the Laboratory Core is to direct training and proficiency testing for Project 1's laboratory functions in Nairobi for Project 1 and to oversee quality control development for testing described in individual projects (e.g.;computerized target cell counting for Projects 1,3 4 and cytokine immune factors for Project 1). Dr. Morrow is experienced in training staff and developing proficiency testing programs in laboratories both locally and outside the United States, including in African sites. The third and final aim is to develop and standardize novel tests for Project 1 for antibody function and for the detection of semen in samples from the genital tract of female subjects. The Core ensures that the Scientific Projects can obtain results from high throughput laboratory testing without redundant effort and waste of resources.

Public Health Relevance

Laboratory Core B provides accurate, cost-effective, centralized laboratory testing for HSV antibodies and HSV DNA in order to meet the scientific aims of the Projects. Laboratory Core B also provides specialized testing for hepatitis and HIV viruses and for human bloodtype markers and oversees quality control aspects of those laboratory procedures that are performed within the projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI030731-24
Application #
8696994
Study Section
Special Emphasis Panel (ZAI1-LR-M)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
24
Fiscal Year
2014
Total Cost
$260,855
Indirect Cost
$53,827
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Schiffer, Joshua T; Swan, Dave A; Roychoudhury, Pavitra et al. (2018) A Fixed Spatial Structure of CD8+ T Cells in Tissue during Chronic HSV-2 Infection. J Immunol 201:1522-1535
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2018) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol 141:1144-1147.e5
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2018) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect 94:568-570
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Kleinstein, Sarah E; Shea, Patrick R; Allen, Andrew S et al. (2018) Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). Genes Immun :
Gilbert, Peter B; Excler, Jean-Louis; Tomaras, Georgia D et al. (2017) Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women. PLoS One 12:e0176428
Celum, Connie; Hong, Ting; Cent, Anne et al. (2017) Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. J Infect Dis 215:907-910
Abana, Chike O; Pilkinton, Mark A; Gaudieri, Silvana et al. (2017) Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects. J Immunol 199:3187-3201
Johnston, Christine; Magaret, Amalia; Roychoudhury, Pavitra et al. (2017) Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents. Virology 510:90-98
Agyemang, Elfriede; Le, Quynh-An; Warren, Terri et al. (2017) Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting. Sex Transm Dis 44:763-767

Showing the most recent 10 out of 345 publications